Illness	Number of cases
Pneumonia organism unspecified - Bronchopneumonia unspecified organism (J18.0)	119
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	98
Pneumonia organism unspecified - Pneumonia unspecified organism (J18.9)	78
Left ventricular failure unspecified (I50.14)	77
Heart failure (I50.01)	74
Essential primary hypertension (I10.91)	68
Atrial fibrillation and flutter - Paroxysmal atrial fibrillation (I48.0)	60
Syncope and collapse (R55)	58
Volume depletion (E86)	51
Essential primary hypertension (I10.01)	44

Top 10 treatments

Treatment	Number
(9-984.7)	387
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	382
(9-984.8)	349
Computed tomography (CT) of the head without contrast medium (3-200)	254
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	231
Computed tomography of the chest with contrast medium (3-222)	195
(9-984.9)	173
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	163
Computed tomography of the abdomen with contrast medium (3-225)	134
(9-984.b)	101

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
23	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
1	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
1	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility